Listed by the USPTO as NGUYEN, NGHI V
Tech Center 1600 • Art Units: 1641 1653 1657 1699
This examiner grants 54% of resolved cases
NGUYEN, NGHI V is a USPTO patent examiner in tech center 1600 and art unit 1641. The record includes 494 resolved cases and a 53.6% allowance rate. Median time to allowance is 1318 days. Interview lift is 50.8%, nearly matching the allowance rate and standing out as an important prosecution signal. The figures support integrating interview planning with written responses and claim amendments.
The main company filers are Wisconsin Alumni Research Foundation, Ricoh Company, Ltd., and Kaneka Corporation. The leading firms are BIRCH STEWART KOLASCH & BIRCH, LLP, Knobbe, Martens, Olson & Bear, LLP, and MORRISON & FOERSTER LLP. The 1318-day median indicates that applicants should preserve flexibility for a longer prosecution course and set expectations accordingly.
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18728767 | CELL CULTURE METHODS | Non-Final OA | THE UNIVERSITY OF MASSACHUSETTS |
| 18375035 | A METHOD OF PRODUCING A CARDIOMYOCYTE SPHEROID | Final Rejection | KANEKA CORPORATION |
| 18310510 | GENERATING ARTERIAL ENDOTHELIAL CELL POPULATIONS | Final Rejection | WISCONSIN ALUMNI RESEARCH FOUNDATION |
| 17609064 | WASHED PLATELET EXTRACT | Final Rejection | WISCONSIN ALUMNI RESEARCH FOUNDATION |
| 17908810 | METHODS AND SYSTEMS TO PRINT AND MATURE TISSUES OVER TIME IN A THREE-DIMENSIONAL SUPPORT MATRIX | Non-Final OA | The General Hospital Corporation |
| 17434912 | A NUTRITIONAL COMPOSITION FOR USE TO ENHANCE EXECUTIVE FUNCTION | Non-Final OA | SOCIETE DES PRODUITS NESTLE S.A. |
| 17479037 | CELL CULTURE CARRIER, AND METHOD AND DEVICE FOR PRODUCING SAME | Non-Final OA | RICOH COMPANY, LTD. |
| 18270368 | Use of Fibroblast Growth Factor-8 For Tissue Regeneration | Non-Final OA | UNIVERSITY OF CONNECTICUT |
| 18026991 | NERVE FASCICLE AND METHOD OF PRODUCING NERVE FASCICLE | Final Rejection | University of Tsukuba |
| 18553584 | IMMUNE MODULATORY PARACRINE ACTING CELLS (IMPACS) | Non-Final OA | Temple University - of the Commonwealth System of Higher Education |
| 17769663 | BIOLOGICALLY SYNTHESIZED HYDROXYAPATITE FOR BONE REGENERATION AND TISSUE ENGINEERING | Final Rejection | BIOVENTURES, LLC |
| 18368070 | METHODS AND COMPOSITIONS FOR IN-VITRO AUGMENTATION OF MILK PRODUCTION FROM MAMMARY EPITHELIAL CELLS | Final Rejection | Yissum Research Development Company of the Hebrew University of Jerusalem Ltd. |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy53.6% of resolved applications examined by Nghi V Nguyen were allowed (494 resolved cases), compared with 45.2% across Art Unit 1641 over the last five years.
This examiner's interview lift is +50.8 percentage points: the difference in allowance rate between resolved applications that had an examiner interview and those that did not.
Applications allowed by Nghi V Nguyen took 1,318 days on average from filing to allowance.
Nghi V Nguyen examines applications in Art Unit 1641 in Tech Center 1600 (Biotechnology & Pharmaceuticals).
